The Fund seeks long term growth of capital. The Fund is a "non-diversified" portfolio and invests primarily in the common stocks of large companies, normally a core position of 20-30 common stocks ...

Porter, MD, as the Society's president for the 2025-2026 term. A long-standing leader in the field of transplantation and cellular therapy, Dr. Porter brings decades of experience in research ...